PI (Department of Defense, Peer Reviewed Cancer Research Program, E01) Long-Term Outcomes after Treatment for Juvenile Pilocytic Astrocytoma.
Co-I (National Cancer Institute, R01) Optimizing Outcomes in AYA Survivors of Pediatric Medulloblastoma (PI: King, Georgia State University).
Co-I (Peach Bowl Legacy Fund) Phase II, Prospective Trial of Poly-ICLC (Hiltonol®) Treatment in Children and Young Adults with Progressive Low-Grade Gliomas (PI: Aguilera).
Co-I (Department of Defense USAMRMC/Office of the Congressionally Directed Medical Research Programs) A Phase II Trial of Poly-ICLC for Progressive, Previously Treated Low-Grade Gliomas in Children and Young Adults with Neurofibromatosis Type 1 (PI: Aguilera).
Co-I (National Cancer Institute, R01) Pediatric Trial of Indoximod with Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG (PI: Johnson, Augusta University)
Co-I (Rising Tide Foundation) Neurocognitive and QoL Outcomes in Pediatric Brain Tumor Survivors in Photon and Proton Treated Cohorts (Emory PI: Eaton).
Co-I (Private Foundation Funded) QOL Monitoring of a Follow-Upon Trial (GCC2020) for Patients on GCC1949 Who Have Tumor Progression (PI: Johnson, Augusta University)
PI (CURE Childhood Cancer) Health Related Quality of Life Outcomes during Molecularly Targeted Therapy for the Treatment of Refractory or Progressive Pediatric Brain Tumors.